Skip to main content

Conditional HIF-1 induction produces multistage neovascularization with stage-specific sensitivity to VEGFR inhibitors and myeloid cell independence.

Publication ,  Journal Article
Oladipupo, SS; Hu, S; Santeford, AC; Yao, J; Kovalski, JR; Shohet, RV; Maslov, K; Wang, LV; Arbeit, JM
Published in: Blood
April 2011

Neovascularization is a crucial component of tumor growth and ischemia. Although prior work primarily used disease models, delineation of neovascularization in the absence of disease can reveal intrinsic mechanisms of microvessel regulation amenable to manipulation in illness. We created a conditional model of epithelial HIF-1 induction in adult mice (TetON-HIF-1 mice). Longitudinal photoacoustic microscopy (L-PAM) was coincidentally developed for noninvasive, label-free serial imaging of red blood cell-perfused vasculature in the same mouse for weeks to months. TetON-HIF-1 mice evidenced 3 stages of neovascularization: development, maintenance, and transgene-dependent regression. Regression occurred despite extensive and tight pericyte coverage. L-PAM mapped microvascular architecture and quantified volumetric changes in neocapillary morphogenesis, arteriovenous remodeling, and microvessel regression. Developmental stage endothelial proliferation down-regulation was associated with a DNA damage checkpoint consisting of p53, p21, and endothelial γ-H2AX induction. The neovasculature was temporally responsive to VEGFR2 immuno-blockade, with the developmental stage sensitive, and the maintenance stage resistant, to DC101 treatment. L-PAM analysis also pinpointed microvessels ablated or resistant to VEGFR2 immuno-blockade. HIF-1-recruited myeloid cells did not mediate VEGFR2 inhibitor resistance. Thus, HIF-1 neovascularization in the absence of disease is self-regulated via cell autonomous endothelial checkpoints, and resistant to angiogenesis inhibitors independent of myeloid cells.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Blood

DOI

EISSN

1528-0020

ISSN

0006-4971

Publication Date

April 2011

Volume

117

Issue

15

Start / End Page

4142 / 4153

Related Subject Headings

  • Vascular Endothelial Growth Factor Receptor-2
  • Vascular Endothelial Growth Factor Receptor-1
  • Tumor Microenvironment
  • Transcriptional Activation
  • Signal Transduction
  • Pericytes
  • Neovascularization, Physiologic
  • Neovascularization, Pathologic
  • Myeloid Cells
  • Microcirculation
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Oladipupo, S. S., Hu, S., Santeford, A. C., Yao, J., Kovalski, J. R., Shohet, R. V., … Arbeit, J. M. (2011). Conditional HIF-1 induction produces multistage neovascularization with stage-specific sensitivity to VEGFR inhibitors and myeloid cell independence. Blood, 117(15), 4142–4153. https://doi.org/10.1182/blood-2010-09-307538
Oladipupo, Sunday S., Song Hu, Andrea C. Santeford, Junjie Yao, Joanna R. Kovalski, Ralph V. Shohet, Konstantin Maslov, Lihong V. Wang, and Jeffrey M. Arbeit. “Conditional HIF-1 induction produces multistage neovascularization with stage-specific sensitivity to VEGFR inhibitors and myeloid cell independence.Blood 117, no. 15 (April 2011): 4142–53. https://doi.org/10.1182/blood-2010-09-307538.
Oladipupo SS, Hu S, Santeford AC, Yao J, Kovalski JR, Shohet RV, et al. Conditional HIF-1 induction produces multistage neovascularization with stage-specific sensitivity to VEGFR inhibitors and myeloid cell independence. Blood. 2011 Apr;117(15):4142–53.
Oladipupo, Sunday S., et al. “Conditional HIF-1 induction produces multistage neovascularization with stage-specific sensitivity to VEGFR inhibitors and myeloid cell independence.Blood, vol. 117, no. 15, Apr. 2011, pp. 4142–53. Epmc, doi:10.1182/blood-2010-09-307538.
Oladipupo SS, Hu S, Santeford AC, Yao J, Kovalski JR, Shohet RV, Maslov K, Wang LV, Arbeit JM. Conditional HIF-1 induction produces multistage neovascularization with stage-specific sensitivity to VEGFR inhibitors and myeloid cell independence. Blood. 2011 Apr;117(15):4142–4153.

Published In

Blood

DOI

EISSN

1528-0020

ISSN

0006-4971

Publication Date

April 2011

Volume

117

Issue

15

Start / End Page

4142 / 4153

Related Subject Headings

  • Vascular Endothelial Growth Factor Receptor-2
  • Vascular Endothelial Growth Factor Receptor-1
  • Tumor Microenvironment
  • Transcriptional Activation
  • Signal Transduction
  • Pericytes
  • Neovascularization, Physiologic
  • Neovascularization, Pathologic
  • Myeloid Cells
  • Microcirculation